Chinese regulators are slowing the pipeline of humanoid-robot initial public offerings as they examine high valuations and the commercial quality of revenue. People familiar with the process described informal “window guidance,” with one calling listings effectively frozen for now and another stressing that no formal ban exists.
The shift followed Unitree Robotics’ volatile Shanghai debut. The maker of humanoid and quadruped robots rose more than fivefold after listing a month earlier, then fell 55% from its peak, sharpening concerns about retail enthusiasm and the durability of sector valuations.
At least six Chinese humanoid-robot companies are preparing to go public, including Deep Robotics, X Square Robot and AGIBOT. The companies did not confirm whether their individual plans had been delayed, so the sector-wide slowdown should not be converted into a stated timetable for each issuer.
Beijing continues to treat embodied intelligence—artificial intelligence that perceives and acts in the physical world—as a strategic emerging industry. The tighter review therefore signals an attempt to cool financial euphoria without abandoning official support for robotics technology.
Regulators are focusing on revenue from local-government-backed data-collection centers and joint ventures. In some projects, local authorities can provide 80% to 90% of the initial investment, creating orders that help companies reach listing thresholds but may not demonstrate demand from independent customers.
One person close to investors estimated that some valuations could fall 60% to 70% if revenue linked to those centers were removed. That is a scenario for selected companies, not an observed decline across the industry, and it depends on how regulators classify each revenue stream.
Mech-Mind Robotics chief executive Shao Tianlan alleged that some highly valued embodied-AI firms relied on data centers, related-party transactions and other unsustainable arrangements while pursuing IPOs. Mech-Mind’s own shares were nearly 20% below their September 1 debut-day high, adding another market signal rather than proving the allegation.
Mainland Chinese companies have raised $148.9 billion through share sales and convertible offerings in 2026, 59% more than a year earlier, with technology accounting for 41%. Capital remains available, but investors and regulators increasingly demand factory deployment, recurring orders and viable use cases before rewarding robotics issuers.